Clarius Group, LLC - NGM BIOPHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 76 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Clarius Group, LLC ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$42,790
+87.2%
26,912
+1.2%
0.00%
+50.0%
Q4 2023$22,855–26,606–0.00%–
 Download
Other shareholders

There were no reported owners of NGM BIOPHARMACEUTICALS INC in Q1 2024.

NameSharesValueWeighting ↓
View complete list of NGM BIOPHARMACEUTICALS INC shareholders